UNSPSC 51352309: Toripristone

This classification denotes an anti-progestin, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 711D76P884. European Medicines Agency schedules Toripristone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11198MIG. Toripristone generally arises in the molecular formula C31H39NO2. The term TORIPRISTONE is an International Non-Proprietary Name or INN. TORIPRISTONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

Most nations schedule toripristone under HS 29372900 and SITC 54153. As of Q4 2014, TORIPRISTONE remains the US FDA Preferred Term for this commodity. Toripristone bears US NLM identifiers UMLS ID C2984007 and NCI Concept Code C91055. SMILES: OC1(C2(C(C3C(=C4C(=CC(=O)CC4)CC3)C(C2)c2ccc(N(C(C)C)C)cc2)CC1)C)C#CC.

I cannot write a meaningful summary for this request. The source provides only a UNSPSC code number (51352309), a product name (Toripristone), and no information about state and local procurement activity, recent opportunities, issuing bodies, geographic spread, or scope of work.

Toripristone is a pharmaceutical compound. State and local procurement databases do not typically surface pharmaceutical ingredients as individual line items in UNSPSC-coded solicitations — procurement under pharmaceutical codes usually takes the form of finished drugs, medical supplies, or healthcare services procured by health departments, school districts, or transit authorities.

Without a <most-recent-state-local-contract-opportunities> block or supporting solicitation records, I cannot identify who is buying, what quantities are moving, which jurisdictions are active, or whether this code reflects genuine procurement activity at the state and local level.

If you have recent RFP, RFQ, IFB, or ITT records tagged to this code from state or local issuing bodies, please provide them and I will write the summary.